Density-dependent variations in the lipid content and metabolism of cultured human keratinocytes.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 2455004)

Published in J Invest Dermatol on July 01, 1988

Authors

M L Williams1, S L Rutherford, M Ponec, M Hincenbergs, D R Placzek, P M Elias

Author Affiliations

1: Dermatology Service, Veterans Administration Medical Center, San Francisco, California 94121.

Articles by these authors

Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science (1995) 3.44

Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol (2001) 2.34

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med (1990) 2.13

Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol (1985) 2.12

Epidermal lipids, barrier function, and desquamation. J Invest Dermatol (1983) 2.09

Rhizobium leguminosarum CFN42 genetic regions encoding lipopolysaccharide structures essential for complete nodule development on bean plants. J Bacteriol (1989) 2.00

The permeability barrier in mammalian epidermis. J Cell Biol (1975) 1.94

Freeze-fracture identification of sterol-digitonin complexes in cell and liposome membranes. J Cell Biol (1978) 1.90

Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res (1986) 1.90

Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol (2001) 1.88

Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest (1992) 1.88

Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev (1997) 1.88

Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr (2002) 1.79

Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction. J Invest Dermatol (1991) 1.76

Membrane sterol heterogeneity. Freeze-fracture detection with saponins and filipin. J Histochem Cytochem (1979) 1.74

Human stratum corneum lipids: characterization and regional variations. J Lipid Res (1983) 1.74

Transepidermal water loss: the signal for recovery of barrier structure and function. J Lipid Res (1989) 1.61

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest (1994) 1.58

Vitamin-A-induced mucous metaplasia. An in vitro system for modulating tight and gap junction differentiation. J Cell Biol (1976) 1.57

Heterogeneity in autosomal recessive ichthyosis. Clinical and biochemical differentiation of lamellar ichthyosis and nonbullous congenital ichthyosiform erythroderma. Arch Dermatol (1985) 1.55

Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res (1989) 1.54

Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds. Antimicrob Agents Chemother (1996) 1.54

Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol (1999) 1.52

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry. Antimicrob Agents Chemother (1996) 1.51

Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest (1981) 1.50

Epidermal lipids, membranes, and keratinization. Int J Dermatol (1981) 1.48

De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res (1985) 1.47

The biochemistry and function of stratum corneum lipids. Adv Lipid Res (1991) 1.47

Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol (1990) 1.44

The mammalian cutaneous permeability barrier: defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest (1978) 1.44

Cyclophilins: a new family of proteins involved in intracellular folding. Trends Cell Biol (1992) 1.39

Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis. J Clin Invest (1984) 1.38

Ultrastructural localization of calcium in psoriatic and normal human epidermis. Arch Dermatol (1991) 1.37

Staphylococcal scalded skin syndrome. Clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol (1977) 1.37

Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res (1987) 1.36

Barrier function regulates epidermal DNA synthesis. J Clin Invest (1991) 1.35

Localization of calcium in murine epidermis following disruption and repair of the permeability barrier. Cell Tissue Res (1992) 1.35

Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res (1998) 1.34

Membrane alterations during cornification of mammalian squamous epithelia: a freeze-fracture, tracer, and thin-section study. Anat Rec (1977) 1.34

The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest (1995) 1.33

Human epidermal lipids: characterization and modulations during differentiation. J Lipid Res (1983) 1.32

Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest (1991) 1.32

Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem (1999) 1.32

Retinoids, cancer, and the skin. Arch Dermatol (1981) 1.30

SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci (1994) 1.30

Lamellar body secretory response to barrier disruption. J Invest Dermatol (1992) 1.27

What is the 'true' function of skin? Exp Dermatol (2002) 1.26

Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest (1990) 1.26

Ultrastructural observations on experimentally induced foreign-body and organized epithelioid-cell granulomas in man. Am J Pathol (1968) 1.26

Effect of fibroblasts on epidermal regeneration. Br J Dermatol (2002) 1.25

Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res (1991) 1.24

Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol (1993) 1.24

Genetically transmitted, generalized disorders of cornification. The ichthyoses. Dermatol Clin (1987) 1.24

Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res (2000) 1.24

The calcium sensing receptor and its alternatively spliced form in murine epidermal differentiation. J Biol Chem (2000) 1.23

Improved grafting method for treatment of burns with autologous cultured human epithelium. Lancet (1986) 1.23

Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest (1993) 1.23

Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy. J Invest Dermatol (1981) 1.23

Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest (1998) 1.23

Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest (1989) 1.22

Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol (2002) 1.22

Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest (1991) 1.21

Role of ceramide 1 in the molecular organization of the stratum corneum lipids. J Lipid Res (1998) 1.20

Isolation and lipid biochemical characterization of stratum corneum membrane complexes: implications for the cutaneous permeability barrier. J Invest Dermatol (1982) 1.20

Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol (1996) 1.20

Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum-free medium. J Cell Physiol (1988) 1.20

Differentiation-related changes of cytokeratin expression in cultured keratinocytes and in fetal, newborn, and adult epidermis. Exp Cell Res (1987) 1.19

Retinoid effects on epidermal structure, differentiation, and permeability. Lab Invest (1981) 1.19

Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. J Invest Dermatol (1985) 1.19

Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol (1996) 1.18

In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol (1988) 1.18

Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol (1995) 1.16

Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. Am J Pathol (1984) 1.15

25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol (2004) 1.15

Mammalian epidermal barrier layer lipids: composition and influence on structure. J Invest Dermatol (1977) 1.15

Phase behavior of isolated skin lipids. J Lipid Res (1996) 1.14

Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol (2000) 1.14

UVB-induced alterations in permeability barrier function: roles for epidermal hyperproliferation and thymocyte-mediated response. J Invest Dermatol (1997) 1.14

Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol (2000) 1.13

Serine-palmitoyl transferase activity in cultured human keratinocytes. J Lipid Res (1990) 1.13

Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha. J Invest Dermatol (1998) 1.13

Antimicrobial activity of stratum corneum lipids from normal and essential fatty acid-deficient mice. J Invest Dermatol (1989) 1.12

Ciliogenesis in human bronchial epithelial cells cultured at the air-liquid interface. Am J Respir Cell Mol Biol (1994) 1.12

Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol (1995) 1.12

1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem (1988) 1.11

Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest (1992) 1.11

Localization and composition of lipids in neonatal mouse stratum granulosum and stratum corneum. J Invest Dermatol (1979) 1.10

Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol (1998) 1.09

Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol (2000) 1.09

Determination of stratum corneum lipid profile by tape stripping in combination with high-performance thin-layer chromatography. Arch Dermatol Res (2001) 1.09

Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol (1993) 1.08

Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol (1997) 1.08

Lipids and the epidermal permeability barrier. Arch Dermatol Res (1981) 1.07

Fatty acids are required for epidermal permeability barrier function. J Clin Invest (1993) 1.07

Toxic epidermal necrolysis in a patient with graft-vs-host reaction. Arch Dermatol (1972) 1.07

Localization of de novo sterologenesis in mammalian skin. J Invest Dermatol (1983) 1.07

Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol (1996) 1.07

Alterations in membrane sugars during epidermal differentiation: visualization with lectins and role of glycosidases. J Histochem Cytochem (1983) 1.06

Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest (1990) 1.06